Aleksandra Antovic
Adjungerad Lektor | Docent
E-postadress: aleksandra.antovic@ki.se
µþ±ð²õö°ì²õ²¹»å°ù±ð²õ²õ: D2:01, Karolinska Universitetssjukhuset, 17176 Stockholm
Postadress: K2 Medicin, Solna, K2 Reuma Antovic A, 171 77 Stockholm
Artiklar
- Journal article: FRONTIERS IN LUPUS. 2025;2:1511382
- Journal article: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2025;17:1759720x251350087
- Article: ARTHRITIS RESEARCH & THERAPY. 2025;27(1):49
- Article: RMD OPEN. 2024;10(4):e004838
- Article: RHEUMATOLOGY. 2024;63(11):3164-3171
- Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2024;46(1):42-49
- Article: PLOS ONE. 2024;19(8):e0309112
- Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(4):418-423
- Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(3):293-301
- Article: FRONTIERS IN MEDICINE. 2023;10:1240325
- Article: VACCINES. 2022;10(12):2046
- Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:761
- Article: JOURNAL OF RHEUMATOLOGY. 2022;49(6):598-606
- Journal article: JOURNAL OF RHEUMATOLOGY. 2022;49(5):547
- Article: THROMBOSIS AND HAEMOSTASIS. 2021;121(10):1299-1309
- Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(5):390-397
- Article: SEMINARS IN THROMBOSIS AND HEMOSTASIS. 2021;47(05):506-511
- Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:693
- Journal article: MEDICUS. 2021;22(1):29-36
- Article: FRONTIERS IN MEDICINE. 2021;8:761453
- Article: FRONTIERS IN IMMUNOLOGY. 2021;12:718845
- Article: OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. 2021;2021:9458587
- Article: JOURNAL OF MOLECULAR MEDICINE-JMM. 2020;98(9):1279-1286
- Article: RHEUMATOLOGY ADVANCES IN PRACTICE. 2020;4(2):rkaa056
- Article: TH OPEN. 2020;4(3):e178-e188
- Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:699-700
- Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2020;42(3):322-330
- Article: BLOOD COAGULATION & FIBRINOLYSIS. 2020;31(4):243-252
- Article: SCIENTIFIC REPORTS. 2020;10(1):7871
- Article: JOURNAL OF RHEUMATOLOGY. 2020;47(5):714-721
- Article: TH OPEN. 2020;4(2):e94-e103
- Article: CLINICAL CHEMISTRY. 2020;66(2):379-389
- Article: CLINICAL RHEUMATOLOGY. 2019;38(11):3005-3014
- Article: LUPUS. 2019;28(7):868-877
- Article: ARTHRITIS CARE & RESEARCH. 2018;70(12):1849-1855
- Article: THROMBOSIS RESEARCH. 2017;158:168-173
- Article: THROMBOSIS AND HAEMOSTASIS. 2017;117(9):1700-1704
- Journal article: THROMBOSIS RESEARCH. 2017;151:s119
- Article: CLINICAL ENDOCRINOLOGY. 2016;84(5):729-735
- Article: THROMBOSIS RESEARCH. 2015;135(6):1124-1130
- Article: THROMBOSIS AND HAEMOSTASIS. 2015;113(2):312-318
- Article: THROMBOSIS RESEARCH. 2014;133(5):936-944
- Article: THROMBOSIS AND HAEMOSTASIS. 2014;111(4):656-661
- Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2013;11(4):697-703
- Article: THROMBOSIS RESEARCH. 2012;130(4):649-653
- Article: THROMBOSIS AND HAEMOSTASIS. 2012;108(1):21-31
- Article: LUPUS. 2012;21(7):802-805
- Article: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2012;34(1):35-40
- Article: DIABETES CARE. 2012;35(2):404-408
- Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2012;20(1):13-18
- Article: THROMBOSIS AND HAEMOSTASIS. 2011;106(2):344-352
- Article: BLOOD COAGULATION & FIBRINOLYSIS. 2011;22(2):127-131
- Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2011;19(4):303-305
- Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2011;19(1):27-32
- Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2011;19(4):259-264
- Article: SEMINARS IN THROMBOSIS AND HEMOSTASIS. 2010;36(7):772-779
- Article: THROMBOSIS RESEARCH. 2010;126(3):e225-e231
- Journal article: ROMANIAN JOURNAL OF LEGAL MEDICINE. 2010;18(4):247-252
- Article: CURRENT VASCULAR PHARMACOLOGY. 2008;6(3):173-185
- Article: BLOOD COAGULATION & FIBRINOLYSIS. 2007;18(4):365-370
- Article: BLOOD COAGULATION & FIBRINOLYSIS. 2005;16(8):585-596
- Article: ANNALS OF THORACIC SURGERY. 2005;80(2):586-593
- Article: BLOOD COAGULATION & FIBRINOLYSIS. 2005;16(1):61-67
- Article: THROMBOSIS RESEARCH. 2005;116(6):509-517
- Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2003;1(12):2531-2535
- Article: THROMBOSIS AND HAEMOSTASIS. 2003;90(4):620-627
- Article: BLOOD COAGULATION & FIBRINOLYSIS. 2003;14(6):551-556
- Article: HAEMOPHILIA. 2002;8(6):781-786
- Article: THROMBOSIS AND HAEMOSTASIS. 2002;88(4):644-647
- Article: BLOOD COAGULATION & FIBRINOLYSIS. 2002;13(3):181-186
- Article: THROMBOSIS RESEARCH. 2001;103(5):355-361
- Visa fler
´¡²Ô²õ³Ùä±ô±ô²Ô¾±²Ô²µ²¹°ù
- Biträdande överläkare, ME Gastro Hud Reuma, Karolinska Universitetssjukhuset, 2021-
- Adjungerad Lektor, Medicin, Solna, ̽»¨¾«Ñ¡, 2020-2025
- Överläkare, Akademiskt specialistcentrum, Centrum för reumatologi, Stockholms läns sjukvårdsområde (SLSO), 2017-2021
Examina och utbildning
- Docent, Koagulationsforskning, ̽»¨¾«Ñ¡, 2015
- MEDICINE DOKTORSEXAMEN, INST F KIRURGISK VETENSKAP (K3), ̽»¨¾«Ñ¡, 2004
Uppdrag
- Forskargruppsledare, Research Group SLE/APS/Vasculitis, Department of Medicine Solna (MEDS), ̽»¨¾«Ñ¡, 2024-
Handledning
- Esin Ylmaz, The impact of female hormonal fluctuations on SLE features and damage, 2023
- Natali Karandyszowska, Diagnostic and therapeutic challenges in patients with antiphospholipid syndrome, 2021
Uppdrag i kommitté
- Medlem, EULAR Study Group on Reproductive Health & Family Planning, European Alliance of Associations for Rheumatology, 2023-
- Medlem, Swedish Rheumatology Association, 2023-
Utvärdering av avhandlingsarbete
- Ebba Westerberg, Examination board member, Department of Medicine, Huddinge, ̽»¨¾«Ñ¡, Molecular Profiling of Chronic Myelomonocytic Leukemia (CMML), 2024
- Shahrzad Kia Komujuni, Examination board member, Department of Medicine Solna, ̽»¨¾«Ñ¡, Optimising treatment outcomes in people leaving with systemic lupus erythematosus, 2022
- Alexander Juto, Examination board member, Department of Clinical Neuroscience & Center for Molecular Medicine (CMM), Neuroimmunology Unit., ̽»¨¾«Ñ¡, Anti-CD20 therapy in multiple sclerosis : clinical and paraclinical outcomes, 2021
- Muna Saleh, Examination board member, Department of Bio̽»¨¾«Ñ¡ & Clinical Sciences Rheumatology/Division of Inflammation & Infection, Linköping University Hospital, Half-time examination. Title: Biomarkers associated with adverse pregnancy outcomes and other disease-related manifestations in systemic lupus erythematosus, 2021
- Karin Hjorton, Examination board member, Uppsala Universitet, Department of Medical Sciences, The activation and regulation of plasmacytoid dendritic cells in SLE and possible therapeutic interventions, 2020
- Margarita Ivanchenko, Examination board member, Department of Medicine, Solna, ̽»¨¾«Ñ¡, Cellular and Molecular Factors in the Pathogenesis of Systemic Autoimmunity and Comorbidities, 2019
- Eva Waldheim, Examination board member, Department of Neurobiology, Care Sciences and Society, Division of Nursing, ̽»¨¾«Ñ¡, When systemic lupus erythematosus (SLE) involves pain: occurrence and impact on daily life, 2018
- Ingrid Lekander, Examination board member, Department of Learning, Informatics, Management and Ethics, ̽»¨¾«Ñ¡, 2017
- Torstein Jensen, Opponent, Hematological Researh Laboratory, Oslo, Norway, University of Oslo, Norway, Studies on subfractions of fibrinogen. With special emphasis on fibrinogen quantification, viscosity and inflammation, 2008